1,889
Participants
Start Date
September 30, 1998
Primary Completion Date
January 31, 2003
Low dose ASA
High dose ASA
Low dose paracetamol
High dose paracetamol
Caffeine
Placebo
Lead Sponsor
Boehringer Ingelheim
INDUSTRY